238 related articles for article (PubMed ID: 26861247)
1. Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption.
Xu L; Luo J; Jin R; Yue Z; Sun P; Yang Z; Yang X; Wan W; Zhang J; Li S; Liu M; Xiao J
Mol Cancer Ther; 2016 May; 15(5):854-65. PubMed ID: 26861247
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone.
Li M; Wang W; Zhu Y; Lu Y; Wan P; Yang K; Zhang Y; Mao C
Acta Biomater; 2018 Sep; 77():365-379. PubMed ID: 30030174
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
Shibuya I; Takami M; Miyamoto A; Karakawa A; Dezawa A; Nakamura S; Kamijo R
Pathol Oncol Res; 2019 Jan; 25(1):409-419. PubMed ID: 29159783
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluoruracil blocked giant cell tumor progression by suppressing osteoclastogenesis through NF-kappaB signals and blocking angiogenesis.
Song D; Meng T; Xu W; Hou T; Lin Z; Yin H; Li B; Zhou L; Wang T; Han S; Fan T; Miao W; Liu M; Luo J; Zhou W; Li Z; Xiao J
Bone; 2015 Sep; 78():46-54. PubMed ID: 25956534
[TBL] [Abstract][Full Text] [Related]
6. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
7. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis
Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J
FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415
[TBL] [Abstract][Full Text] [Related]
8. Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone.
Mills BG; Frausto A
Calcif Tissue Int; 1997 Jul; 61(1):16-21. PubMed ID: 9192505
[TBL] [Abstract][Full Text] [Related]
9. Nanosized Alumina Particle and Proteasome Inhibitor Bortezomib Prevented inflammation and Osteolysis Induced by Titanium Particle via Autophagy and NF-κB Signaling.
Zhang Z; Fu X; Xu L; Hu X; Deng F; Yang Z; Jiang L; Fu T; Zhou P; Song J; Ji P; Huang J; Wu X
Sci Rep; 2020 Mar; 10(1):5562. PubMed ID: 32221318
[TBL] [Abstract][Full Text] [Related]
10. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
[TBL] [Abstract][Full Text] [Related]
11. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib inhibits human osteoclastogenesis.
von Metzler I; Krebbel H; Hecht M; Manz RA; Fleissner C; Mieth M; Kaiser M; Jakob C; Sterz J; Kleeberg L; Heider U; Sezer O
Leukemia; 2007 Sep; 21(9):2025-34. PubMed ID: 17581612
[TBL] [Abstract][Full Text] [Related]
13. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
14. Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.
Lee K; Kim MY; Ahn H; Kim HS; Shin HI; Jeong D
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946669
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.
Ang ES; Pavlos NJ; Chim SM; Feng HT; Scaife RM; Steer JH; Zheng MH; Xu J
J Cell Biochem; 2012 Mar; 113(3):946-55. PubMed ID: 22034016
[TBL] [Abstract][Full Text] [Related]
16. Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.
Boissy P; Andersen TL; Lund T; Kupisiewicz K; Plesner T; Delaissé JM
Leuk Res; 2008 Nov; 32(11):1661-8. PubMed ID: 18394701
[TBL] [Abstract][Full Text] [Related]
17. Stromal Cell-Derived CCL20 Promotes Tumor Progression and Osteolysis in Giant Cell Tumor of Bone.
Zhao C; Wang D; Tang L; Zhang Z; Li S; Qian M; Wu Z; Zhou W; Liu M; Luo J; Liu T; Li Z; Xiao J
Cell Physiol Biochem; 2018; 51(5):2472-2483. PubMed ID: 30537747
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.
Balke M; Campanacci L; Gebert C; Picci P; Gibbons M; Taylor R; Hogendoorn P; Kroep J; Wass J; Athanasou N
BMC Cancer; 2010 Aug; 10():462. PubMed ID: 20799989
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.
Cao F; Liu T; Xu Y; Xu D; Feng S
Int J Clin Exp Pathol; 2015; 8(6):6037-45. PubMed ID: 26261481
[TBL] [Abstract][Full Text] [Related]
20. Narlumosbart: First Approval.
Dhillon S
Drugs; 2024 Jan; 84(1):105-109. PubMed ID: 38112898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
